Call Today: (866) 459-0066
Contact us for free information or to start a free case review.
The Food and Drug Administration finalized on Friday its earlier action to strengthen the label on certain dyes used for magnetic resonance imaging, or MRI. The dyes will now carry a bold black box to warn of a potentially fatal side effect in some kidney and liver patients.
In May, the FDA announced that gadolinium-based contrast agents would receive the heightened warning after reports linked the agents to a rare and deadly disease known as nephrogenic systemic fibrosis (NSF).
The disease is characterized by a thickening of the skin, organs, and other tissues and there is currently no cure or effective course of treatment. According to one study, the risk of NSF in patients with severe kidney insufficiency who receive an injection with a gadolinium-based dye is 4 percent.
Patients scheduled to undergo an MRI should be screened for kidney problems first. The FDA said no cases of NSF have been reported in patients with normal kidney function.
(Source: Reuters online)
Diagnosed with NSF? Contact an attorney today to discuss your legal options.
Copyright © 2001 - 2012 Online Lawyer Source
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.